DOW JONES28,992.41-227.57 -0.78%
S&P 5003,337.75-35.48 -1.05%
NASDAQ9,576.59-174.38 -1.79%

Bernstein Downgrades Gilead Sciences to Market Perform, Lowers Price Target to $70

Bernstein analyst Aaron Gal downgrades Gilead Sciences (NASDAQ:GILD) from Outperform to Market Perform and lowers the price target from $78 to $70.

Benzinga · 02/06/2020 10:38

Bernstein analyst Aaron Gal downgrades Gilead Sciences (NASDAQ:GILD) from Outperform to Market Perform and lowers the price target from $78 to $70.